Literature DB >> 12777698

Estradiol exerts neuroprotective actions against ischemic brain injury: insights derived from animal models.

Phyllis Wise1.   

Abstract

Over the last 100 yr, the life-span of women has increased from 50 yr to over 80 yr, but the age of the menopause has remained unchanged, at 51 yr. Menopause is one of the most permanent physiologic changes that a woman will experience and is marked by a dramatic decrease in circulating levels of ovarian estrogens. Because the timing of menopause has remained fixed in the face of an increasing life-span, more women will live a greater proportion of their lives in a hypoestrogenic state. We appreciate more and more that the actions of ovarian steroid hormones are complex, and possibly exert opposing actions in different contexts. I review here the results of my laboratory's recent studies that clearly establish that low physiologic levels of estradiol replacement can exert profound neuroprotective actions when administered prior to an ischemic strokelike injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777698     DOI: 10.1385/endo:21:1:11

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  23 in total

Review 1.  Recovery recapitulates ontogeny.

Authors:  S C Cramer; M Chopp
Journal:  Trends Neurosci       Date:  2000-06       Impact factor: 13.837

Review 2.  Estrogens: trophic and protective factors in the adult brain.

Authors:  P M Wise; D B Dubal; M E Wilson; S W Rau; Y Liu
Journal:  Front Neuroendocrinol       Date:  2001-01       Impact factor: 8.606

3.  Estradiol protects against injury-induced cell death in cortical explant cultures: a role for estrogen receptors.

Authors:  M E Wilson; D B Dubal; P M Wise
Journal:  Brain Res       Date:  2000-08-11       Impact factor: 3.252

4.  Stroke in estrogen receptor-alpha-deficient mice.

Authors:  K Sampei; S Goto; N J Alkayed; B J Crain; K S Korach; R J Traystman; G E Demas; R J Nelson; P D Hurn
Journal:  Stroke       Date:  2000-03       Impact factor: 7.914

5.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 6.  Estrogen as a neuroprotectant in stroke.

Authors:  P D Hurn; I M Macrae
Journal:  J Cereb Blood Flow Metab       Date:  2000-04       Impact factor: 6.200

7.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

Authors:  R A Mulnard; C W Cotman; C Kawas; C H van Dyck; M Sano; R Doody; E Koss; E Pfeiffer; S Jin; A Gamst; M Grundman; R Thomas; L J Thal
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

8.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

9.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

10.  Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury.

Authors:  D B Dubal; H Zhu; J Yu; S W Rau; P J Shughrue; I Merchenthaler; M S Kindy; P M Wise
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  13 in total

1.  Acute estradiol protects CA1 neurons from ischemia-induced apoptotic cell death via the PI3K/Akt pathway.

Authors:  Teresa Jover-Mengual; Takahiro Miyawaki; Adrianna Latuszek; Enrique Alborch; R Suzanne Zukin; Anne M Etgen
Journal:  Brain Res       Date:  2010-01-28       Impact factor: 3.252

2.  17β-estradiol increases expression of the oxidative stress response and DNA repair protein apurinic endonuclease (Ape1) in the cerebral cortex of female mice following hypoxia.

Authors:  Alicia K Dietrich; Gwendolyn I Humphreys; Ann M Nardulli
Journal:  J Steroid Biochem Mol Biol       Date:  2013-07-29       Impact factor: 4.292

3.  MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia.

Authors:  Teresa Jover-Mengual; R Suzanne Zukin; Anne M Etgen
Journal:  Endocrinology       Date:  2006-11-30       Impact factor: 4.736

4.  Effects of estrogen on platelet reactivity after transient forebrain ischemia in rats.

Authors:  Marguerite T Littleton-Kearney; Jessica M Gaines; Kevin P Callahan; Stephanie J Murphy; Patricia D Hurn
Journal:  Biol Res Nurs       Date:  2005-10       Impact factor: 2.522

5.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

6.  Cerebral hypoperfusion increases estrogen receptor abundance in the ovine fetal brain and pituitary.

Authors:  Charles E Wood
Journal:  Neuroendocrinology       Date:  2007-12-21       Impact factor: 4.914

Review 7.  Neuroprotective actions of brain aromatase.

Authors:  Colin J Saldanha; Kelli A Duncan; Bradley J Walters
Journal:  Front Neuroendocrinol       Date:  2009-05-18       Impact factor: 8.606

8.  Recovery of motor and cognitive function after cerebellar lesions in a songbird: role of estrogens.

Authors:  Rory D Spence; Yin Zhen; Stephanie White; Barney A Schlinger; Lainy B Day
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

Review 9.  Traumatized and inflamed--but resilient: glial aromatization and the avian brain.

Authors:  Kelli A Duncan; Bradley J Walters; Colin J Saldanha
Journal:  Horm Behav       Date:  2012-03-05       Impact factor: 3.492

10.  Neuroinflammation induces glial aromatase expression in the uninjured songbird brain.

Authors:  Kelli A Duncan; Colin J Saldanha
Journal:  J Neuroinflammation       Date:  2011-07-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.